NRAS and neoplasm: The mutational status of BRAF and NRAS in the four PTC variants (cPTC, PTMC, PTMC-FV and PTC/FV) was compared to the clinicopathological parameters, including age, gender, tumor size, extracapsular extension, lymphovascular involvement, lymph node metastasis, and multifocality.